Improved radioimmunotherapy of hematologic malignancies. Final technical report
Experiments were performed to study the rates of endocytosis, intracellular routing, and metabolic degradation of radiolabeled monoclonal antibodies targeting tumor-associated antigens on human leukemia and lymphoma cells. An attempt was made to examine in vivo the effects of lysosomotropic amines and thioamides on the retention of radiolabeled monoclonal antibodies by tumor cells. Experiments also examined the impact of newer radioiodination techniques on the metabolic degradation of radioiodinated antibodies, and on the radioimmunoscintigraphy and radioimmunotherapy of neoplasms. The endocytosis, intracellular routing, and degradation of radioimmunoconjugates prepared with I-131, In-111, and Y-90 were compared. The utility of radioimmunoconjugates targeting oncogene products for the radioimmunotherapy and radioimmunoscintigraphy of cancer was investigated.
- Research Organization:
- Washington Univ., Seattle, WA (United States)
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- DOE Contract Number:
- FG06-92ER61459
- OSTI ID:
- 373849
- Report Number(s):
- DOE/ER/61459-4; ON: DE96014768; TRN: 96:024922
- Resource Relation:
- Other Information: PBD: 15 Aug 1996
- Country of Publication:
- United States
- Language:
- English
Similar Records
Improved radioimmunotherapy of hematologic malignancies. [Final report]
Improved radioimmunotherapy of hematologic malignancies. Progress report, 1988--1991